PPHC Public Reporting
ACO Name & Location
Premier Patient Healthcare, LLC
2340 East Trinity Mills
Carrollton, TX 75006
ACO Primary Contact
Organizational Information:
ACO Participants:
| ACO Participants | ACO Participant in Joint Venture |
| ADEL A ZAKHARY PA | N |
| ADVANCED FAMILY MEDICAL CARE PA | N |
| AGNES KINRA MD, PA | N |
| ALLEN FRIENDS & FAMILY CLINIC PLLC | N |
| ANJANI AMIN, MD PA | N |
| ARCHANA CHANDRA MDPA | N |
| BHARMAL INTERNAL MEDICINE ASSOCIATES,P.A. | N |
| BROOKS TROTTER | N |
| CENTENNIAL PRIMARY CARE PLLC | N |
| DAVID N PODGURECKI, MD PA | N |
| DONALD WHITCOMB | N |
| DR. TANVIR AHMAD AND DR. FAUZIA KHALIDA OSAMA M.D. PA | N |
| FRELYN LOUGHRIDGE FAMILY NURSE PRACTITIONER PC | N |
| HAMID BURNEY, M.D., P.A. | N |
| JAISWAL CLINIC PLLC | N |
| JALIL KHAN, MD, PA | N |
| JIAUL AHSAN PLLC | N |
| JOHN FERRIS | N |
| KEITH WILKERSON | N |
| KEVIN J KALLAL MD PA | N |
| LIFES CYCLE WOMENS CARE PC | N |
| LOUIS A TORRES JR MD. PLLC | N |
| MARK R. KLEIN, D.O. & ASSOCIATES, PLLC | N |
| MARTYN GORDON | N |
| MCKINNEY ADULT MEDICINE, PA | N |
| MICHELLE ABBE HACKER PLLC | N |
| NORTH COUNTRY FAMILY PRACTICE, PA | N |
| PHP INS TX PLLC | N |
| PRESTON MEDICAL ASSOCIATES PA | N |
| ROBERT R. MCLEROY, M.D. & ASSOCIATES A PROFESSIONAL LLC | N |
| SONG LEE | N |
| SOPHIA RAHMAN MD PLLC | N |
| SOUTHERN MEDICAL ASSOCIATES PLLC | N |
| SOUTHWARD FAMILY MEDICINE | N |
| STEVE WATKINS DO PC | N |
| TEXAS FAMILICARE MEDICAL GROUP PLLC | N |
| THOMAS J MILLER PA | N |
| TIMARRON FAMILY MEDICINE PA | N |
| TRUESMEDICINE PA | N |
ACO governing body
|
Member Last Name |
Member First Name |
Member Title/Position |
Member’s Voting Power (Expressed as a percentage or number) | Membership Type | ACO Participant Legal Business Name and D/B/A, if applicable |
| Ahmad | Tanvir | M.D., Medical Director, Voting Member | 14.3% | ACO Participant Representative | Dr. Tanvir Ahmad and Dr. Fauzia Khalida Osama M.D. PA |
| Jaiswal | Deepak | M.D., Chairman, Voting Member | 14.3% | ACO Participant Representative | Jaiswal Clinic PLLC |
| Parisi | Michael | D.O., Vice Chairman, Voting Member | 14.3% | ACO Participant Representative | McKinney Adult Medicine, PA |
| Khan | Jalil | M.D., Voting Member | 14.3% | ACO Participant Representative | Jalil Khan, MD, PA |
| Lee | Song | M.D., Voting Member | 14.3% | ACO Participant Representative | Song Lee |
| Wilkerson | Keith | M.D., Voting Member | 14.3% | ACO Participant Representative | Keith Wilkerson |
| Coletta | Cindy | Voting Member | 7.1% | Medicare Beneficiary Representative | N/A |
| Kazi | Mohammad | Voting Member | 7.1% | Other/ACO Management Representative | N/A |
Key ACO clinical and administrative leadership
ACO Executive: Mohammad Kazi
Medical Director: Tanvir Ahmad, MD
Compliance Officer: Tiffany Marcks
Quality Assurance/Improvement Officer: Kathy Johnson
Associated committees and committee leadership
Regional board members serve as the region’s committee for quality, utilization, engagement, finance
| Committee Name | Committee Leader Name and Position |
|
Arlington Regional Board Grapevine Regional Board
|
Hamid Burney, MD, Chair Chris King, MD, Chair
|
Types of ACO participants, or combinations of participants, that formed the ACO
- Network of individual practices of ACO professionals
Shared Savings and Losses:
Amount of Shared Savings/Losses
- Third Agreement Period
- Performance Year 2020, $4,298,247
- Second Agreement Period
- Performance Year 2019, $4,472,389
- Performance Year 2018, $1,523,320
- Performance Year 2017, $2,215,242
- First Agreement Period
- Performance Year 2016, $12,568,102
- Performance Year 2015, $5,835,335
- Performance Year 2014, $5,806,261
Shared Savings Distribution:
- Third Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: 51%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 49%
- Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 55%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 45%
- Performance Year 2018
- Proportion invested in infrastructure: 47%
- Proportion invested in redesigned care processes/resources: 13%
- Proportion of distribution to ACO participants: 40%
- Performance Year 2017
- Proportion invested in infrastructure: 27%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 73%
- First Agreement Period
- Performance Year 2016
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 75%
- Performance Year 2015
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 75%
- Performance Year 2014
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 75%
- Performance Year 2016
- Performance Year 2019
- Performance Year 2020
Quality Performance Results
2020 Quality Performance Results:
| ACO Quality Measure Number | Measure Name | Rate | ACO Mean |
| ACO43 | Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91) | 0.75 | 0.95 |
| ACO13 | Falls: Screening for Future Fall Risk | 83.18 | 84.97 |
| ACO14 | Preventive Care and Screening: Influenza Immunization | 80.21 | 76.03 |
| ACO17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 83.33 | 81.67 |
| ACO18 | Preventive Care and Screening for Clinical Depression and Follow-up Plan | 55.51 | 71.46 |
| ACO19 | Colorectal Cancer Screening | 70.20 | 72.59 |
| ACO20 | Breast Cancer Screening | 66.28 | 74.05 |
| ACO42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 75.30 | 83.37 |
| ACO27 | Diabetes: Hemoglobin A1c Poor Control | 11.11 | 14.70 |
| ACO28 | Controlling High Blood Pressure | 79.78 | 72.87 |
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov